| Name | Title | Contact Details |
|---|---|---|
Greg Martini |
Vice President, Strategic Finance and Investor Relations | Profile |
Cheryl McCarthy |
Director, Research Quality Assurance | Profile |
Sharon DeBacco |
VP Product Promotion & Communication | Profile |
Alexander Bryant |
Vice President, Research and External Innovation | Profile |
Sravan Emany |
Chief Financial Officer | Profile |
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company`s allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
Verdezyne is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases. Our founders` groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source.
CMAC Consultancy is a Vernon Hills, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carterra, formerly Wasatch Microfluidics, develops high throughput surface plasmon resonance array-based platforms for biomolecular interaction analysis.